期刊文献+

二甲双胍对内毒素性肝损伤的保护效应与过氧化氢酶的关联性研究

Potential Association between the Protective Effects of Metformin and Catalase in Mice with Endotoxic Liver Injury
原文传递
导出
摘要 目的本实验在前期发现二甲双胍可减轻脂多糖/右旋半乳糖胺诱导的内毒素性肝损伤的基础上,进一步探讨二甲双胍保肝效应与过氧化氢酶的可能关联。方法雄性Balb/c小鼠经腹腔注射脂多糖/右旋半乳糖胺诱导急性肝损伤,随后检测二甲双胍对肝内过氧化氢酶活性的影响并观察过氧化氢酶抑制剂氨基三唑可否阻断二甲双胍对肝损伤的保护效应。结果二甲双胍处理可提高脂多糖/右旋半乳糖胺暴露小鼠肝内过氧化氢酶活性、降低过氧化氢及丙二醛水平。过氧化氢酶抑制剂氨基三唑可明显消除二甲双胍对模型小鼠肝内过氧化氢酶活性的增强作用,但氨基三唑仅能部分消除二甲双胍对过氧化氢水平的抑制作用,氨基三唑不能消除二甲双胍对丙二醛生成、血浆丙氨酸氨基转移酶和天冬氨酸氨基转移酶升高的抑制效应,氨基三唑也不能消除二甲双胍对模型小鼠肝组织病变的改善效应。结论本实验结果提示二甲双胍可增强脂多糖/右旋半乳糖胺暴露小鼠肝组织内过氧化氢酶活性,但这一效应在二甲双胍的保肝效应中不具有重要意义。 OBJECTIVE We previously found the hepatoprotective effects of metformin (Met) in mice with lipopolysaccharide/D- galactosamine (LPS/D-Gal)-induced endotoxic liver injury, the present studies were designed to further explore the potential associa- tion between the hepatoprotective effects of Met and catalse (CAT). METHODS Acute liver injury was induced by intraperitoneal injection of LPS/D-Gal. The activity of hepatic CAT was determined and whether the CAT inhibitor aminotriazole (ATZ) could abolish the protective effects of Met was tested. RESULTS Met enhanced the activity of CAT in the liver of LPS/D-Gal-exposed mice, sup- pressed the elevation of hydrogen peroxide ( H202 ) and malondialdehyde (MDA). The CAT inhibitor ATZ obviously suppressed the stimulatory effects of Met on CAT activity, but ATZ partially reversed the suppressive effects of Met on H202 content. ATZ did not re- verse the inhibitory effects of Met on MDA production or ALT and AST elevation, it has no effects on morphological abnormalites. CONCLUSION These data suggest although Met can improve the activity of CAT in LPS/D-Gal challenged mice, these effects seem not important for the protective benefits of Met.
出处 《中国药学杂志》 CAS CSCD 北大核心 2015年第5期399-402,共4页 Chinese Pharmaceutical Journal
基金 国家自然科学基金资助项目(81370179)
关键词 二甲双胍 过氧化氢酶 氧化应激 肝损伤 脂多糖 metformin catalase oxidative stress liver injury lipopolysaceharide
  • 相关文献

参考文献12

  • 1MAHMOOD K, NAEEM M, RAHIMNAJJAD N A. Metformin: The hidden chronicles of a magic drug [J]. Eur J Intern Med, 2013, 24( 1 ) :20-26.
  • 2FORETZ M, HEBRARD S, LECLERC J, et al. Metformin in- hibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state[ J ]. J Clin Invest, 2010, 120(7) :2355-2369.
  • 3DAI J, LIU M, AI Q, et al. Involvement of catalase in the pro- tective benefits of metformin in mice with oxidative liver injury [J]. Chem Biol Interact, 2014, 216:34-42.
  • 4YUAN H, LI L, ZHENG W, et al. Antidiabetic drug metfonnin alleviates endotoxin-induced fulminant liver injury in mice [ J ]. lnt lmmunopharmacol, 2012,12 (4) :682-688.
  • 5DAO V T, FLOEREN M, KUMPF S, et al. Catalase activity prevents exercise-induced up-regulation of vasoprotective proteins in venous tissue [ J]. J Cell Mol Med, 2011, 15 ( 11 ) :2326- 2334.
  • 6SILVERSTEIN R. D-galaetosamine lethality model: Scope and limitations[ J ]. J Endotoxin Res, 2004, 10 (3) : 147-162.
  • 7JIA M, JING Y, AI Q, et al. Potential role of catalase in mice with lipopolysaeeharide/D-galaetosamine-induced fulminant liver injury [J]. Hepatol Res, 2014, 44(11):1151-1158.
  • 8HOU X, SONG J, LI X N, et al. Metformin reduces intracellular reactive oxygen species levels by upregulating expression of the antioxidant thioredoxin via the AMPK-FOXO3 pathway [ J ]. Bio- chem Biophys Res Commun, 2010, 396(2) :199-205.
  • 9PIWKOWSKA A, ROGACKA D, JANKOWSKI M, et al. Met- formin induces suppression of NAD ( P ) H oxidase activity in podoeytes [ J]. Biochem Biophys Res Commun, 2010, 393 (2) : 268 -273.
  • 10PIWKOWSKA A, ROGACKA D, JANKOWSKI M, et al. Met- formin reduces NAD ( P ) H oxidase activity in mouse cultured podocytes through purinergic dependent mechanism by increasing extraeellular ATP concentration [J] Acta Biochim Pol, 2013, 60 (4) :607-612.

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部